110 related articles for article (PubMed ID: 3907686)
1. Urinary pseudouridine excretion in myelomatosis.
Sørensen SH; Brown DA; Cooper EH; Kelly KA; MacLennan IC
Br J Cancer; 1985 Dec; 52(6):863-6. PubMed ID: 3907686
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of beta 2-microglobulin in myeloma patients.
Engström W; Hyldahl L; Wahrgren P
Clin Chim Acta; 1980 Dec; 108(3):369-74. PubMed ID: 6162592
[TBL] [Abstract][Full Text] [Related]
3. Correlations of pseudouridine in 8-hour and 24-hour urinary samples determined by high-performance liquid chromatography.
Sjølin KE
Urol Res; 1982; 10(5):245-8. PubMed ID: 7164220
[TBL] [Abstract][Full Text] [Related]
4. Urinary levels of pseudouridine in patients with psoriasis determined by high-performance liquid chromatography.
Nagayo K; Way BH
Arch Dermatol Res; 1982; 274(3-4):335-8. PubMed ID: 7165377
[TBL] [Abstract][Full Text] [Related]
5. Urinary pseudouridine as a biochemical marker in the diagnosis and monitoring of primary hepatocellular carcinoma.
Tamura S; Fujioka H; Nakano T; Amuro Y; Hada T; Nakao N; Higashino K
Am J Gastroenterol; 1988 Aug; 83(8):841-5. PubMed ID: 2456010
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of beta-aminoisobutyrate and pseudouridine in acute and chronic myeloid leukemia.
Nielsen HR; Killmann SA
J Natl Cancer Inst; 1983 Nov; 71(5):887-91. PubMed ID: 6580488
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of pseudouridine in patients with hepatocellular carcinoma.
Tamura S; Amuro Y; Nakano T; Fujii J; Moriwaki Y; Yamamoto T; Hada T; Higashino K
Cancer; 1986 Apr; 57(8):1571-5. PubMed ID: 2418945
[TBL] [Abstract][Full Text] [Related]
8. Urinary alpha 1- and beta 2-microglobulin in light chain proteinuria.
Honkanen E; Pettersson T; Teppo AM
Clin Nephrol; 1995 Jul; 44(1):22-7. PubMed ID: 7554529
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis.
Cuzick J; Cooper EH; MacLennan IC
Br J Cancer; 1985 Jul; 52(1):1-6. PubMed ID: 3893505
[TBL] [Abstract][Full Text] [Related]
10. Pseudouridine: a prognostic marker in non-Hodgkin's lymphomas.
Rasmuson T; Björk GR
Cancer Detect Prev; 1985; 8(1-2):287-90. PubMed ID: 4064048
[TBL] [Abstract][Full Text] [Related]
11. Urinary pseudouridine and beta-aminoisobutyric acid in patients with low grade urothelial tumours. Relations between excretion and tumour recurrence.
Nyholm KK; Sjolin KE; Wolf H; Hammer M; Knudsen J; Stahl D; Nielsen HR
Biomedicine; 1976 May; 25(3):85-7. PubMed ID: 949520
[TBL] [Abstract][Full Text] [Related]
12. Pseudouridine: a modified nucleoside as biological marker in malignant lymphomas.
Rasmuson T; Björk GR
Cancer Detect Prev; 1983; 6(1-2):293-6. PubMed ID: 6883387
[TBL] [Abstract][Full Text] [Related]
13. Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring.
Norfolk D; Child JA; Cooper EH; Kerruish S; Ward AM
Br J Cancer; 1980 Oct; 42(4):510-5. PubMed ID: 6159910
[TBL] [Abstract][Full Text] [Related]
14. Detection of elevated amounts of urinary pseudouridine in cancer patients by use of a monoclonal antibody.
Itoh K; Mizugaki M; Ishida N
Clin Chim Acta; 1989 May; 181(3):305-15. PubMed ID: 2758683
[TBL] [Abstract][Full Text] [Related]
15. Long-term prognostic value of serum beta 2 microglobulin in myelomatosis.
Cuzick J; De Stavola BL; Cooper EH; Chapman C; MacLennan IC
Br J Haematol; 1990 Aug; 75(4):506-10. PubMed ID: 2119793
[TBL] [Abstract][Full Text] [Related]
16. Urinary pseudouridine/creatinine ratio as an indicator of gastrointestinal cancer.
Higley B; De Mello J; Oakes DJ; Giles GR
Br J Surg; 1982 Dec; 69(12):699-701. PubMed ID: 7171969
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of urinary and serum pseudouridine in diagnosis and monitoring of primary liver cancer.
Tu Z; Xu S; Wu M
Chin Med J (Engl); 1995 Mar; 108(3):204-8. PubMed ID: 7796629
[TBL] [Abstract][Full Text] [Related]
18. Pseudouridine excretion in patients with psoriasis.
Clemmensen OJ; Kieffer M; Sjølin KE
Acta Derm Venereol; 1987; 67(4):310-4. PubMed ID: 2445149
[TBL] [Abstract][Full Text] [Related]
19. Age dependence of human urinary pseudouridine excretion.
Tritsch GL; Luch JM; Evans JT; Mittelman A
Biochem Med; 1979 Dec; 22(3):387-90. PubMed ID: 533544
[No Abstract] [Full Text] [Related]
20. Urinary pseudouridine as a tumor marker in patients with small cell lung cancer.
Tamura S; Fujii J; Nakano T; Hada T; Higashino K
Clin Chim Acta; 1986 Jan; 154(2):125-32. PubMed ID: 3006946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]